Phase 2 Study of Xevinapant + Chemoradiotherapy (CRT) Vs Placebo + CRT in Patients with Unresected Locally Advanced Squamous Cell Carcinoma of the Head and Neck (LA SCCHN): A Post Hoc Activity Analysis by Blinded Independent Review Committee Evaluation.